These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36175801)

  • 21. APE1 shRNA-loaded cancer stem cell-derived extracellular vesicles reverse Erlotinib resistance in non-small cell lung cancer via the IL-6/STAT3 signalling.
    Tang CH; Qin L; Gao YC; Chen TY; Xu K; Liu T; Ren T
    Clin Transl Med; 2022 May; 12(5):e876. PubMed ID: 35605028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic Role of Heterogeneous Nuclear Ribonucleoprotein C in Multiple Cancer Types, with a Particular Focus on Lung Adenocarcinoma, Using a Pan-Cancer Analysis and Cell Line Experiments.
    Zhang L; Peng H; Jiang L
    J Environ Pathol Toxicol Oncol; 2022; 41(3):77-93. PubMed ID: 35993957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non-small cell lung cancer after concurrent chemoradiation.
    Liu Y; Fan J; Xu T; Ahmadinejad N; Hess K; Lin SH; Zhang J; Liu X; Liu L; Ning B; Liao Z; Hu TY
    Sci Adv; 2020 Mar; 6(11):eaaz6162. PubMed ID: 32195353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis.
    Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C
    Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. m6A RNA methylation modification is involved in the disease course of heart failure.
    Yu L; Cai S; Guo X
    Biotechnol Genet Eng Rev; 2024 Oct; 40(2):961-975. PubMed ID: 36943073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
    Li D; Fu Z; Dong C; Song Y
    Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RALY may cause an aggressive biological behavior and a dismal prognosis in non-small-cell lung cancer.
    Song G; Guo G; Du T; Li X; Wang J; Yan Y; Zhao Y
    Exp Cell Res; 2020 Apr; 389(2):111884. PubMed ID: 32014444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular vesicles released by non-small cell lung cancer cells drive invasion and permeability in non-tumorigenic lung epithelial cells.
    Hasan H; Sohal IS; Soto-Vargas Z; Byappanahalli AM; Humphrey SE; Kubo H; Kitdumrongthum S; Copeland S; Tian F; Chairoungdua A; Kasinski AL
    Sci Rep; 2022 Jan; 12(1):972. PubMed ID: 35046472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites.
    Thuya WL; Kong LR; Syn NL; Ding LW; Cheow ESH; Wong RTX; Wang T; Goh RMW; Song H; Jayasinghe MK; Le MT; Hu JC; Yong WP; Lee SC; Wong AL; Sethi G; Hung HT; Ho PC; Thiery JP; Sze SK; Guo T; Soo RA; Yang H; Lim YC; Wang L; Goh BC
    Theranostics; 2023; 13(2):621-638. PubMed ID: 36632230
    [No Abstract]   [Full Text] [Related]  

  • 32. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX; Zhou KC; Cao Y
    Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer.
    Cheng Y; Li L; Wei X; Xu F; Huang X; Qi F; Zhang Y; Li X
    Cancer Sci; 2023 May; 114(5):1830-1845. PubMed ID: 36718950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme.
    Wang LC; Chen SH; Shen XL; Li DC; Liu HY; Ji YL; Li M; Yu K; Yang H; Chen JJ; Qin CZ; Luo MM; Lin QX; Lv QL
    Front Oncol; 2020; 10():536875. PubMed ID: 33134160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.
    Zhou J; Xiao D; Qiu T; Li J; Liu Z
    Technol Cancer Res Treat; 2020; 19():1533033820977525. PubMed ID: 33280517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
    Tang X; Zhou H; Liu Y
    Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma.
    Guo W; Huai Q; Zhang G; Guo L; Song P; Xue X; Tan F; Xue Q; Gao S; He J
    Front Oncol; 2020; 10():598437. PubMed ID: 33569346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
    Liu T; Li C; Jin L; Li C; Wang L
    Med Sci Monit; 2019 Dec; 25():9435-9445. PubMed ID: 31823961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new m6A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder.
    Zheng B; Wang J; Zhao G; Chen X; Yao Z; Niu Z; He W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.